Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. From left to right: Michael ...

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients ...

Lexaria’s after-hours surge came after the company filed with the Securities and Exchange Commission on Thursday, revealing that it had ended its “Capital on Demand” Sales Agreement with JonesTrading ...

With each new study, the horizon of GLP-1’s therapeutic potential expands, painting a vibrant picture of a future where a single molecule could tackle a multitude of human afflictions, including ...

Lexx Season 4 is here and the team is back to tackle all the dangers that threaten to destroy the universe. The fourth season aired from July 13, 2001 to April 26, 2002, and received fairly positive ...

Lexaria Bioscience Corp. (NASDAQ: LEXX) on Tuesday provided an update on its Phase 1b, 12-week chronic study GLP-1-H24-4, recently completed in Australia, focusing on 4 DehydraTECH ( DHT) study arms ...

A while ago I did a review of the first LEXX DVD, S2 V1, and promised to do the rest of the second season in the coming weeks. How can I put this delicately... I lied. It's been months. But I'm ...

Over the last two months, Lexaria Bioscience Corporation (NASDAQ:LEXX) has advanced several new initiatives, reported first quarter earnings and outlined a bold plan for 2022 which includes the launch ...